Fig. 8From: Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemiaThe effect of BBR on CHPT1, PLA2G4A, LCAT and UGCG protein of liver tissues in hyperlipidemic hamsters (Immunohistochemistry, 400 ×). Compared with NFD group, ***p < 0.001; Compared with HFD group, ###p < 0.001). Data are presented as mean ± SD (n = 6)Back to article page